Plasma Protease C1-inhibitor Treatment Market Sustains Competitiveness by Adoption of Technological Innovations
Wilmington, Delaware, United States: The vendor landscape of the global market for plasma protease c1-inhibitor treatment market is largely consolidated with a handful of companies collectively accounting for a lion's share in the market and maintaining a tough level of competition, observes Transparency Market Research in a recent report.
Read Report Overview - https://www.transparencymarketresearch.com/plasma-protease-c1inhibitor-treatment-market.html
The company Shire plc. held the dominant spot in the market, thanks to its expansive product portfolio and extensive geographical reach. Other leading companies in the market, including CSL Limited, Pharming Group N.V., and Sanquin are focused on expanding their geographical outreach, product portfolios, and startegic collaborations to establish a stronghold on the market.
According to the report, the global plasma protease c1-inhibitor treatment market will exhibit an impressive 20.0% CAGR from 2017 to 2025. Considering that the numbers hold true, the market is expected to rise from a valuation of US$1.5 bn in 2016 to a revenue opportunity of US$7.9 bn by the end of 2025.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=33116
North America Takes Lead; to Retain Dominance as HAE and Prophylaxis Cases Rise
Of the key drug classes used in plasma protease C1-inhibitor treatment covered under the report, the segment of C1-inhibitors accounted for the dominant share in the market in 2016. The wide usage of this drug class for the treatment of conditions such as prophylaxis and acute hereditary angioedema (HAE) is likely to keep their demand steady across the globe.
Geographically, the global plasma protease c1-inhibitor treatment market acquires a large share of its revenue from sales across the North America region. The regional market presents high demand for plasma protease c1-inhibitor treatment owing to the high number of HAE cases in the U.S.
Request for Analysis of COVID-19 Impact on Plasma Protease C1-inhibitor Treatment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=33116
Rise in Research Efforts Aimed at Development of Novel C1-inhibitor Drug Classes to Bode Well for Market
The rising awareness regarding the available treatment options for HAE is one of the key factors driving the global plasma protease C1-inhibitor treatment market. Other contributing factors include the steadily expanding pipeline of novel drug classes and formulations, thanks to an increase in investment for the research and development of inhibitor drugs, and the rising prevalence of acute HAE and prophylaxis globally.
The market is also benefitting from the rising practice of prescribing prophylactic treatment procedure for HAE patients, increased focus on the research related to a new route of administering C1-inhibitor medicines, and increased demand for subcutaneous administration of C1-inhibitor drugs in HAE patient.
Make an Enquiry before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=33116
Furthermore, the market could also benefit from the increased availability of C1-inhibitor drugs such as Ruconest in emerging economies with vast unmet needs in the area of HAE and prophylaxis treatment. Research efforts underway aimed at the development of bradykinin B2 receptor antagonist for HAE attack treatment is also likely to work in favor of the market.
More Trending Reports by Transparency Market Research –
Pulmonary Arterial Hypertension Market: https://www.transparencymarketresearch.com/pulmonary-arterial-hypertension-therapeutics.html
Forensic Technologies Market: https://www.transparencymarketresearch.com/forensics-technology.html
Microbiology Culture Market: https://www.transparencymarketresearch.com/us-microbiology-culture-market.html
Nanomedicine Market: https://www.transparencymarketresearch.com/nanomedicine-market.html
Smart Medical Devices Market: https://www.transparencymarketresearch.com/smart-medical-devices-market.html
Bioinformatics Market: https://www.transparencymarketresearch.com/bioinformatics-market.html
Taurine Market: https://www.transparencymarketresearch.com/taurine-market.html
Telehealth Market: https://www.transparencymarketresearch.com/telehealth-market.html
About Us
Transparency Market Research is a global market research firm offering the latest market research reports and business consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453